FOXJ2 and androgen insensitivity syndrome: AlphaLISA demonstrated that the serum levels of DIDO1-Ab, FOXJ2-Ab, and CPSF2-Ab were significantly higher in patients with AIS than in HDs (Fig. 2a, g and 3d).